China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy
- Written by PR Newswire
-- pitolisant is the first and only treatment drug approved in mainland China for narcolepsy.
SHANGHAI, July 4, 2023 /PRNewswire/ -- RareStone Group, a rare disease-focused company aiming to establish the first rare disease ecosystem in China, announced that on June 30, the Chinese National Medical Products Administration (NMPA)...
Read more: China NMPA approves RareStone's pitolisant (Wakix) for the treatment of narcolepsy